Viking Global Investors — ORIC İşlem Geçmişi
ORIC PHARMACEUTICALS INC pozisyonunun çeyrek çeyrek değişimi · CUSIP 68622P109
Elde tutuluyor · 2.5 Yılİlk görüldüğü çeyrek: 2024 Q1
| Çeyrek | Bildirim | İşlem | Adet | Δ Adet | Δ % | Değer | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-14 | Azalttı | 5,126,762 | -697,771 | -12.0% | $55.5M | 0.16% |
| 2026 Q1 | 2026-05-15 | Azalttı | 5,824,533 | -748,158 | -11.4% | $73.8M | 0.21% |
| 2025 Q4 | 2026-02-17 | Azalttı | 6,572,691 | -9 | -0.0% | $53.8M | 0.14% |
| 2025 Q3 | 2025-11-14 | Tuttu | 6,572,700 | — | 0.0% | $78.9M | 0.20% |
| 2025 Q2 | 2025-08-14 | Tuttu | 6,572,700 | — | 0.0% | $66.7M | 0.19% |
| 2025 Q1 | 2025-05-15 | Artırdı | 6,572,700 | 2,141,692 | +48.3% | $36.7M | 0.12% |
| 2024 Q4 | 2025-02-14 | Artırdı | 4,431,008 | 431,008 | +10.8% | $35.8M | 0.12% |
| 2024 Q3 | 2024-11-14 | Tuttu | 4,000,000 | — | 0.0% | $41.0M | 0.15% |
| 2024 Q2 | 2024-08-14 | Tuttu | 4,000,000 | — | 0.0% | $28.3M | 0.11% |
| 2024 Q1 | 2024-05-15 | Yeni | 4,000,000 | 4,000,000 | — | $55.0M | 0.20% |
| 2023 Q4 | 2024-02-14 | — | — | — | — | — | — |
| 2023 Q3 | 2023-11-14 | — | — | — | — | — | — |
| 2023 Q2 | 2023-08-14 | — | — | — | — | — | — |
| 2023 Q1 | 2023-05-15 | — | — | — | — | — | — |
| 2022 Q4 | 2023-02-14 | — | — | — | — | — | — |
| 2022 Q3 | 2022-11-14 | — | — | — | — | — | — |
| 2022 Q2 | 2022-08-15 | — | — | — | — | — | — |
| 2021 Q3 | 2022-05-16 | — | — | — | — | — | — |
| 2021 Q4 | 2022-05-16 | — | — | — | — | — | — |
| 2022 Q1 | 2022-05-16 | — | — | — | — | — | — |
| 2021 Q2 | 2021-08-16 | — | — | — | — | — | — |
| 2021 Q1 | 2021-05-17 | — | — | — | — | — | — |
| 2020 Q4 | 2021-02-16 | — | — | — | — | — | — |
| 2020 Q3 | 2020-11-16 | — | — | — | — | — | — |
| 2020 Q2 | 2020-08-07 | — | — | — | — | — | — |
| 2020 Q1 | 2020-05-13 | — | — | — | — | — | — |
| 2019 Q4 | 2020-02-13 | — | — | — | — | — | — |
| 2019 Q3 | 2019-11-13 | — | — | — | — | — | — |
| 2019 Q2 | 2019-08-14 | — | — | — | — | — | — |
| 2019 Q1 | 2019-05-15 | — | — | — | — | — | — |
| 2018 Q4 | 2019-02-14 | — | — | — | — | — | — |
| 2018 Q3 | 2018-11-14 | — | — | — | — | — | — |
| 2018 Q2 | 2018-08-14 | — | — | — | — | — | — |
| 2018 Q1 | 2018-05-15 | — | — | — | — | — | — |
| 2017 Q4 | 2018-02-14 | — | — | — | — | — | — |
| 2017 Q3 | 2017-11-14 | — | — | — | — | — | — |
| 2017 Q2 | 2017-08-14 | — | — | — | — | — | — |
| 2017 Q1 | 2017-05-15 | — | — | — | — | — | — |
| 2016 Q4 | 2017-02-14 | — | — | — | — | — | — |
| 2016 Q3 | 2016-11-14 | — | — | — | — | — | — |
Adetler bölünme düzeltmeli (split-adjusted). Elde tutma süresi, en son çeyrekle biten kesintisiz çeyrek sayısından hesaplanır; 10 yıl üstü ">10 Yıl" olarak gösterilir.
13F verisi çeyrek sonu pozisyonlarını gösterir, 45 güne kadar gecikmelidir ve yalnızca ABD borsalarındaki uzun (long) pozisyonları kapsar; açığa satışlar, türevler ve ABD dışı varlıklar bildirilmez.